AzTrials
AzTrials

Primary DysmenorrheaNCT07239232

"Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea

An observational study of Primary Dysmenorrhea, run by Cairo University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of the study is to assess knee joint position sense, pain and dynamic balance in female with primary dysmenorrhea. Read more about this study

Who is it for?
Ages 18 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
Primary Dysmenorrhea
How many people
62 participants
Where
1 siteEgypt
Study dates
18 Nov 2025to 30 Jan 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Sixty-two healthy female university students will participate in this study. They will be selected randomly from faculty of physical therapy, Cairo University.

Who may be able to join

  • They should be virgin, healthy female students
  • They have regular menstruation (3-8 days in duration, with 21-35 days in-between).
  • They should have the same activity level mild active female.
  • Their ages will range from 18 to 25 years old.
  • Their body mass index (BMI) will range from 18 to 24.9 Kg/m2.

Who cannot join

  • History of knee injury, surgery in the knee or spinal vertebrae.
  • Females having any vestibular problems, otitis media, labyrinthitis or any inner ear problems that affect balance
  • Women with any cognitive deficits
  • History of neuromuscular or spinal disease.
  • History of pelvic pathology or any gynecological disease.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Eman B ABDUL HAMID, B.Sc contact

01158876852

emanahmed2033e@gmail.com

ELHAM s HASSAN, PhD contact

01206146539

elhamramdan70@cu.edu.eg

Egypt1 site, 1 recruiting
  • Cairo University

    Giza

    EMAN B ABDUL HAMID, B.Sc, 01158876852, emanahmed2033e@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Assessment Of Knee Joint Position Sense And Dynamic Balance IN Female With Primary Dysmenorrhea

The purpose of the study is to assess knee joint position sense, pain and dynamic balance in female with primary dysmenorrhea.

Read the detailed description

Dysmenorrhea is a common condition that typically occurs on its own rather than as a result of pelvic disease. It affects between 50% and 90% of adolescent girls and women of reproductive age and is a major reason for missed days from school or work.

Among the various menstrual disturbances observed, dysmenorrhea was notably prevalent among adolescents and significantly impacted their daily activities. Early diagnosis and awareness of menstrual issues are crucial, as they not only emphasize the need for health education initiatives but also assist in selecting suitable treatments, thereby reducing the adverse effects of these disturbances on adolescents' lives.

However, there is a significant gap in the literature about the effect of Primary dysmenorrhea on knee joint position sense, pain and dynamic balance in young adult female So this study aims to investigate this effect and provide evidence based information in the field of physical therapy.

Being tested
No intervention
Keywords
Knee, Position sense, Balance, Primary Dysmenorrhea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    No intervention

Study groups in NCT07239232
Study groupRoleWhat they receive
Asymptomatic GroupThey have no or mild primary dysmenorrhea.
Receives: Other: No intervention
Symptomatic GroupThey have moderate and sever primary dysmenorrhea.
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall Stability Index (OSI) . Antero-posterior stability index score (APSI) . Medio lateral stability index score (MLSI) . Over all stability index score (OASI)

    The Overall Stability Index (OSI) is the primary measure of dynamic postural control obtained from the balance assessment system. It reflects the standard deviation of the participant's sway from the platform's center across both the medial-lateral and anterior-posterior directions. Higher OSI values indicate greater instability and poorer balance performance. As an integrated measure of sway variability, the OSI is considered the most comprehensive indicator of overall balance ability and is commonly used to evaluate changes in postural control in response to therapeutic interventions.

    Measured: at first and fourth menstrual days

  2. Medial-Lateral Stability Index (MLSI)

    The Medial-Lateral Stability Index (MLSI) quantifies the degree of side-to-side sway during balance testing. It represents the standard deviation of medial-lateral movement from the platform's center point, providing a directional measure of postural stability. Elevated MLSI scores reflect increased lateral instability, which may be associated with impaired neuromuscular control or deficits in weight-shifting ability. This variable is useful for identifying balance impairments that predominantly affect frontal plane stability.

    Measured: at first and fourth menstrual days

  3. Anterior-Posterior Stability Index (APSI)

    The Anterior-Posterior Stability Index (APSI) measures front-to-back sway during dynamic balance assessment. Calculated as the standard deviation of anterior-posterior deviations from the center of the platform, the APSI provides insight into sagittal plane stability. Higher APSI values indicate greater instability and reduced capacity to control forward and backward movements. This index is important for evaluating postural control related to gait, stepping, and activities requiring controlled anterior or posterior shifts in the center of gravity.

    Measured: at first and fourth menstrual days

  4. knee joint position sense

    using active knee position sense test by universal goniometer.

    Measured: at first and fourth menstrual days

Secondary outcomes (1)
  1. knee joint pain

    It will be assessed using the Visual analog scale (VAS) for all females in both groups. They will score their level of pain from 1-10, with higher scores indicating more severe pain. It is valid and reliable in pain assessment

    Measured: at first and fourth menstrual days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2025
  2. Study start18 Nov 2025
  3. Primary completion20 Jan 2026 (estimated)
  4. Study completion30 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
62 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07239232
Sponsor's protocol ID
P.T.REC/012/005972
Status last verified
Dec 2025
First submitted
16 Nov 2025
Last updated
12 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Dysmenorrhea, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eman B ABDUL HAMID, B.Sc (01158876852, emanahmed2033e@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall Stability Index (OSI) . Antero-posterior stability index score (APSI) . Medio lateral stability index score (MLSI) . Over all stability index score (OASI) (time frame: at first and fourth menstrual days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in